Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Airway Therapeutics

Airway Therapeutics

Series D+US
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$50.0Msum of rounds with a disclosed amount only
Named investors
0
Financing history
1 rounds
  1. Aug 25, 2026
    Late-Stage · $50.0M (disclosed)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Airway Therapeutics Closes $50 Million Equity Round to Advance Late-Stage Development of Zelpultide Alfa”
Investors on record
0 edges
No named investor yet.
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Aug 25, 2026
    Airway Therapeutics announced Late-Stage of $50,000,000
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company